Thomas Stephen Basil
SEC CIK 2027962 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CLYM | Climb Bio, Inc. | Dir | 468.0K | — | $2.25M | 8 | 2024-06-27 | 2026-09-15 |
Most active insiders at CLYM, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Thomas Stephen Basil | Dir | — | $2.25M |
| 2 | Kolchinsky Peter | Dir, 10% | $754.7K | — |
| 3 | Brennan Aoife | Pres, CEO, Dir | — | $407.0K |
| 4 | RA Capital Healthcare Fund LP | Dir, 10% | $24.9K | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T | 2026-09-17 16:15 | 2026-09-15 | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | S - Sale | $13.67 | -100.0K | 468.0K | -18% | -$1.37M |
| MT | 2026-02-27 | 2026-02-25+ | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | S - Sale | $7.00 | -50.0K | 154.7K | -24% | -$350.2K |
| MT | 2026-02-17 | 2026-02-12+ | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | S - Sale | $5.29 | -100.0K | 204.7K | -33% | -$528.8K |
| 2025-08-11 | 2025-08-07 | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | A - Grant | $0.00 | +100.4K | 304.7K | +49% | $0 | |
| D | 2025-07-01 | 2025-06-27 | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | M - OptEx | — | +25.1K | 204.3K | +14% | — |
| D | 2025-03-27 | 2025-03-27 | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | M - OptEx | — | +25.1K | 179.2K | +16% | — |
| D | 2025-01-03 | 2025-01-01 | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | M - OptEx | — | +50.2K | 154.1K | +48% | — |
| D | 2024-06-27 | 2024-06-27 | CLYM | Climb Bio, Inc. | Thomas Stephen Basil | Dir | A - Grant | — | +103.9K | 103.9K | New | — |
Purchase Sale Sale after option exercise All abbreviations